Compounds > hydrazine
Page last updated: 2024-08-21

hydrazine and Focal Neurologic Deficits

hydrazine has been researched along with Focal Neurologic Deficits in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HIGHMAN, B; MALING, HM1
FRIERSON, WB1
HIGHMAN, B; MALING, HM; SPECTOR, S1
Bogdanov, NA1
Kornet, MJ; Lubawy, WC; Thorstenson, JH1
Barbeau, A; Gillo-Joffroy, L; Mars, H1

Reviews

1 review(s) available for hydrazine and Focal Neurologic Deficits

ArticleYear
[Clinical aspects and diagnosis of chronic poisonings with the components of rocket fuels].
    Voenno-meditsinskii zhurnal, 1974, Issue:1

    Topics: Aerospace Medicine; Ammonia; Chronic Disease; Fluoride Poisoning; Fossil Fuels; Humans; Hydrazines; Military Medicine; Monomethylhydrazine; Neurologic Manifestations; Nitrates; Nitrogen Oxides; Poisoning; Space Flight

1974

Other Studies

5 other study(ies) available for hydrazine and Focal Neurologic Deficits

ArticleYear
Neuropathologic lesions in dogs after prolonged administration of phenylisopropylhydrazine (JB 516) and phenylisobutylhydrazine (JB 835).
    The Journal of pharmacology and experimental therapeutics, 1962, Volume: 137

    Topics: Animals; Central Nervous System; Dogs; Hydrazines; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Phenylhydrazines

1962
USE OF PYRIDOXINE HCL IN ACUTE HYDRAZINE AND UDMH INTOXICATION.
    Industrial medicine & surgery, 1965, Volume: 34

    Topics: Drug Therapy; Humans; Hydrazines; Neurologic Manifestations; Poisoning; Pyridoxine; Toxicology

1965
Neurologic, neuropathologic, and neurochemical effects of prolonged administration of phenylisopropylhydrazine (JB 516), phenylisobutylhydrazine (JB 835), and other monoamine oxidase inhibitors.
    The Journal of pharmacology and experimental therapeutics, 1962, Volume: 137

    Topics: Central Nervous System Depressants; Humans; Hydrazines; Monoamine Oxidase Inhibitors; Nervous System; Neurologic Manifestations; Neurosciences; Phenylhydrazines

1962
Anticonvulsant activity of 1-alkyl-4-substituted 3,5-pyrazolidinediones.
    Journal of pharmaceutical sciences, 1974, Volume: 63, Issue:7

    Topics: Alkylation; Animals; Anticonvulsants; Chemical Phenomena; Chemistry; Electroshock; Hydrazines; Magnetic Resonance Spectroscopy; Male; Malonates; Mice; Neurologic Manifestations; Pentylenetetrazole; Phenytoin; Pyrazoles; Spectrophotometry, Infrared; Succinimides; Time Factors

1974
Adverse clinical side effects of levodopa therapy.
    Contemporary neurology series, 1971, Volume: 8

    Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Edema; Endocrine System Diseases; Feeding and Eating Disorders; Hematopoiesis; Humans; Hydrazines; Libido; Movement Disorders; Myocardial Infarction; Nausea; Neurologic Manifestations; Respiration; Time Factors; Uric Acid; Urination Disorders; Vomiting

1971